{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:12:35Z","timestamp":1794262355496,"version":"4.9.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73406-4","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:15:41Z","timestamp":1780028141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Highly potent C-type nanoantibodies neutralize Nipah and Hendra viruses by cavity filling on fusion glycoprotein"],"prefix":"10.1038","volume":"17","author":[{"given":"Shengdong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guibo","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-8590","authenticated-orcid":false,"given":"Yanfeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-8925","authenticated-orcid":false,"given":"Sheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9034-5755","authenticated-orcid":false,"given":"Sandra","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-5642","authenticated-orcid":false,"given":"Rui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"73406_CR1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/d41586-024-02513-3","volume":"632","author":"S Mallapaty","year":"2024","unstructured":"Mallapaty, S. The pathogens that could spark the next pandemic. Nature 632, 488 (2024).","journal-title":"Nature"},{"key":"73406_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/imm.13695","volume":"171","author":"G Mishra","year":"2023","unstructured":"Mishra, G., Prajapat, V. & Nayak, D. Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics. Immunology 171, 155\u2013169 (2023).","journal-title":"Immunology"},{"key":"73406_CR3","unstructured":"WHO. Nipah virus infection\u2014India. https:\/\/wwww.hoint\/emergencies\/disease-outbreak-news\/item\/2026-DON593 (2026)."},{"key":"73406_CR4","unstructured":"WHO. Nipah virus infection\u2014Bangladesh. https:\/\/wwww.hoint\/emergencies\/disease-outbreak-news\/item\/2026-DON594 (2026)."},{"key":"73406_CR5","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/S1473-3099(23)00707-7","volume":"24","author":"MZ Hassan","year":"2024","unstructured":"Hassan, M. Z. et al. Nipah virus disease: What can we do to improve patient care? Lancet Infect. Dis. 24, e463\u2013e471 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"73406_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/v16020179","volume":"16","author":"J Faus-Cotino","year":"2024","unstructured":"Faus-Cotino, J., Reina, G. & Pueyo, J. Nipah virus: a multidimensional update. Viruses 16, 179 (2024).","journal-title":"Viruses"},{"key":"73406_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/20477724.2024.2380131","volume":"118","author":"SS Vasudevan","year":"2024","unstructured":"Vasudevan, S. S. et al. Global and regional mortality statistics of Nipah virus from 1994 to 2023: a comprehensive systematic review and meta-analysis. Pathog. Glob. Health 118, 471\u2013480 (2024).","journal-title":"Pathog. Glob. Health"},{"key":"73406_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s00705-024-06143-y","volume":"169","author":"P Simmonds","year":"2024","unstructured":"Simmonds, P. et al. Changes to virus taxonomy and the ICTV Statutes ratified by the International Committee on Taxonomy of Viruses (2024). Arch. Virol. 169, 236 (2024).","journal-title":"Arch. Virol."},{"key":"73406_CR9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMc2202705","volume":"387","author":"XA Zhang","year":"2022","unstructured":"Zhang, X. A. et al. A zoonotic henipavirus in febrile patients in China. N. Engl. J. Med. 387, 470\u2013472 (2022).","journal-title":"N. Engl. J. Med."},{"key":"73406_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nature03838","volume":"436","author":"OA Negrete","year":"2005","unstructured":"Negrete, O. A. et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436, 401\u2013405 (2005).","journal-title":"Nature"},{"key":"73406_CR11","doi-asserted-by":"publisher","first-page":"9953","DOI":"10.1073\/pnas.0804797105","volume":"105","author":"K Xu","year":"2008","unstructured":"Xu, K. et al. Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc. Natl. Acad. Sci. USA 105, 9953\u20139958 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73406_CR12","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1128\/JVI.01318-12","volume":"86","author":"YP Chan","year":"2012","unstructured":"Chan, Y. P. et al. Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins. J. Virol. 86, 11457\u201311471 (2012).","journal-title":"J. Virol."},{"key":"73406_CR13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3389\/fimmu.2020.00842","volume":"11","author":"RJ Loomis","year":"2020","unstructured":"Loomis, R. J. et al. Structure-based design of Nipah virus vaccines: a generalizable approach to paramyxovirus immunogen development. Front. Immunol. 11, 842 (2020).","journal-title":"Front. Immunol."},{"key":"73406_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/tmi.13979","volume":"29","author":"V Rodrigue","year":"2024","unstructured":"Rodrigue, V., Gravagna, K., Yao, J., Nafade, V. & Basta, N. E. Current progress towards prevention of Nipah and Hendra disease in humans: a scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials. Trop. Med. Int. Health 29, 354\u2013364 (2024).","journal-title":"Trop. Med. Int. Health"},{"key":"73406_CR15","doi-asserted-by":"publisher","first-page":"25057","DOI":"10.1073\/pnas.1912503116","volume":"116","author":"VA Avanzato","year":"2019","unstructured":"Avanzato, V. A. et al. A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex. Proc. Natl. Acad. Sci. USA 116, 25057\u201325067 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73406_CR16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41594-019-0308-9","volume":"26","author":"HV Dang","year":"2019","unstructured":"Dang, H. V. et al. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections. Nat. Struct. Mol. Biol. 26, 980\u2013987 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"73406_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41594-021-00584-8","volume":"28","author":"HV Dang","year":"2021","unstructured":"Dang, H. V. et al. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins. Nat. Struct. Mol. Biol. 28, 426\u2013434 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"73406_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36995-y","volume":"14","author":"PO Byrne","year":"2023","unstructured":"Byrne, P. O. et al. Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein. Nat. Commun. 14, 1494 (2023).","journal-title":"Nat. Commun."},{"key":"73406_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00638-24","volume":"98","author":"VA Avanzato","year":"2024","unstructured":"Avanzato, V. A. et al. A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from disease. J. Virol. 98, e0063824 (2024).","journal-title":"J. Virol."},{"key":"73406_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39278-8","volume":"14","author":"A Isaacs","year":"2023","unstructured":"Isaacs, A. et al. Structure and antigenicity of divergent Henipavirus fusion glycoproteins. Nat. Commun. 14, 3577 (2023).","journal-title":"Nat. Commun."},{"key":"73406_CR21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314990121","volume":"121","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Structure and design of Langya virus glycoprotein antigens. Proc. Natl. Acad. Sci. USA 121, e2314990121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73406_CR22","unstructured":"May, A. J. et al. Mechanistic and antigenic boundaries of henipavirus and parahenipavirus glycoproteins. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2024.12.11.627382v5 (2025)."},{"key":"73406_CR23","doi-asserted-by":"publisher","first-page":"27288","DOI":"10.1074\/jbc.M111.254219","volume":"286","author":"R Gong","year":"2011","unstructured":"Gong, R., Wang, Y., Feng, Y., Zhao, Q. & Dimitrov, D. S. Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor. J. Biol. Chem. 286, 27288\u201327293 (2011).","journal-title":"J. Biol. Chem."},{"key":"73406_CR24","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1021\/mp400075f","volume":"10","author":"R Gong","year":"2013","unstructured":"Gong, R. et al. N-terminal truncation of an isolated human IgG1 CH2 domain significantly increases its stability and aggregation resistance. Mol. Pharm. 10, 2642\u20132652 (2013).","journal-title":"Mol. Pharm."},{"key":"73406_CR25","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1021\/acs.molpharmaceut.9b00544","volume":"16","author":"X Gao","year":"2019","unstructured":"Gao, X. et al. Optimization of the C-terminus of an autonomous human IgG1 CH2 domain for stability and aggregation resistance. Mol. Pharm. 16, 3647\u20133656 (2019).","journal-title":"Mol. Pharm."},{"key":"73406_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2019.1689027","volume":"12","author":"G Cao","year":"2020","unstructured":"Cao, G. et al. An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific binding. MAbs 12, 1689027 (2020).","journal-title":"MAbs"},{"key":"73406_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4887","volume":"33","author":"S De Felice","year":"2024","unstructured":"De Felice, S. et al. Crystal structure of human serum albumin in complex with megabody reveals unique human and murine cross-reactive binding site. Protein Sci. 33, e4887 (2024).","journal-title":"Protein Sci."},{"key":"73406_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.csbj.2023.11.056","volume":"23","author":"AV Madsen","year":"2024","unstructured":"Madsen, A. V. et al. Structural trends in antibody-antigen binding interfaces: a computational analysis of 1833 experimentally determined 3D structures. Comput. Struct. Biotechnol. J. 23, 199\u2013211 (2024).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"73406_CR29","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.drudis.2016.04.003","volume":"21","author":"S Steeland","year":"2016","unstructured":"Steeland, S., Vandenbroucke, R. E. & Libert, C. Nanobodies as therapeutics: big opportunities for small antibodies. Drug Discov. Today 21, 1076\u20131113 (2016).","journal-title":"Drug Discov. Today"},{"key":"73406_CR30","first-page":"1","volume":"30","author":"MM Al Qaraghuli","year":"2016","unstructured":"Al Qaraghuli, M. M. & Ferro, V. A. Analysis of the binding loops configuration and surface adaptation of different crystallized single-domain antibodies in response to various antigens. J. Mol. Recognit. 30, 1\u201312 (2016).","journal-title":"J. Mol. Recognit."},{"key":"73406_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/pro.70095","volume":"34","author":"K Yamamoto","year":"2025","unstructured":"Yamamoto, K. et al. Affinity-stability trade-off mechanism of residue 35 in framework region 2 of V(H)H antibodies with \u03b2-hairpin CDR3. Protein Sci. 34, e70095 (2025).","journal-title":"Protein Sci."},{"key":"73406_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/v16020195","volume":"16","author":"AJ May","year":"2024","unstructured":"May, A. J. & Acharya, P. Structural studies of henipavirus glycoproteins. Viruses 16, 195 (2024).","journal-title":"Viruses"},{"key":"73406_CR33","doi-asserted-by":"publisher","first-page":"14681","DOI":"10.1074\/jbc.M109.067090","volume":"285","author":"N Kondo","year":"2010","unstructured":"Kondo, N., Miyauchi, K., Meng, F., Iwamoto, A. & Matsuda, Z. Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain. J. Biol. Chem. 285, 14681\u201314688 (2010).","journal-title":"J. Biol. Chem."},{"key":"73406_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ymeth.2015.05.021","volume":"90","author":"WT Saw","year":"2015","unstructured":"Saw, W. T., Matsuda, Z., Eisenberg, R. J., Cohen, G. H. & Atanasiu, D. Using a split luciferase assay (SLA) to measure the kinetics of cell-cell fusion mediated by herpes simplex virus glycoproteins. Methods 90, 68\u201375 (2015).","journal-title":"Methods"},{"key":"73406_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/science.adm8693","volume":"384","author":"DS Zyla","year":"2024","unstructured":"Zyla, D. S. et al. A neutralizing antibody prevents postfusion transition of measles virus fusion protein. Science 384, eadm8693 (2024).","journal-title":"Science"},{"key":"73406_CR36","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00433-23","volume":"97","author":"AJ May","year":"2023","unstructured":"May, A. J., Pothula, K. R., Janowska, K. & Acharya, P. Structures of Langya Virus fusion protein ectodomain in pre- and postfusion conformation. J. Virol. 97, e0043323 (2023).","journal-title":"J. Virol."},{"key":"73406_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature12442","volume":"501","author":"D Corti","year":"2013","unstructured":"Corti, D. et al. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. Nature 501, 439\u2013443 (2013).","journal-title":"Nature"},{"key":"73406_CR38","doi-asserted-by":"publisher","first-page":"S471","DOI":"10.1093\/infdis\/jiz515","volume":"221","author":"CE Mire","year":"2020","unstructured":"Mire, C. E. et al. A cross-reactive humanized monoclonal antibody targeting fusion glycoprotein function protects ferrets against lethal Nipah virus and Hendra virus infection. J. Infect. Dis. 221, S471\u2013S479 (2020).","journal-title":"J. Infect. Dis."},{"key":"73406_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl2055","volume":"16","author":"L Zeitlin","year":"2024","unstructured":"Zeitlin, L. et al. Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates. Sci. Transl. Med. 16, eadl2055 (2024).","journal-title":"Sci. Transl. Med."},{"key":"73406_CR40","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1086\/528801","volume":"197","author":"Z Zhu","year":"2008","unstructured":"Zhu, Z. et al. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J. Infect. Dis. 197, 846\u2013853 (2008).","journal-title":"J. Infect. Dis."},{"key":"73406_CR41","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1473-3099(19)30634-6","volume":"20","author":"EG Playford","year":"2020","unstructured":"Playford, E. G. et al. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. Lancet Infect. Dis. 20, 445\u2013454 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"73406_CR42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/2211-5463.13850","volume":"15","author":"NS El Salamouni","year":"2024","unstructured":"El Salamouni, N. S., Cater, J. H., Spenkelink, L. M. & Yu, H. Nanobody engineering: computational modelling and design for biomedical and therapeutic applications. FEBS Open Bio 15, 236\u2013253 (2024).","journal-title":"FEBS Open Bio"},{"key":"73406_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1389548","volume":"11","author":"IC Swart","year":"2024","unstructured":"Swart, I. C., Van Gelder, W., De Haan, C. A. M., Bosch, B. J. & Oliveira, S. Next generation single-domain antibodies against respiratory zoonotic RNA viruses. Front. Mol. Biosci. 11, 1389548 (2024).","journal-title":"Front. Mol. Biosci."},{"key":"73406_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51066-6","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein. Nat. Commun. 15, 6892 (2024).","journal-title":"Nat. Commun."},{"key":"73406_CR45","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1007\/s00262-022-03170-z","volume":"71","author":"Y Sato","year":"2022","unstructured":"Sato, Y. et al. Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy. Cancer Immunol. Immunother. 71, 2421\u20132431 (2022).","journal-title":"Cancer Immunol. Immunother."},{"key":"73406_CR46","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/mr\/road038","volume":"33","author":"T Takeuchi","year":"2023","unstructured":"Takeuchi, T. Structural, nonclinical, and clinical features of ozoralizumab: a novel tumour necrosis factor inhibitor. Mod. Rheumatol. 33, 1059\u20131067 (2023).","journal-title":"Mod. Rheumatol."},{"key":"73406_CR47","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0002-9440(10)63569-9","volume":"163","author":"KT Wong","year":"2003","unstructured":"Wong, K. T. et al. A golden hamster model for human acute Nipah virus infection. Am. J. Pathol. 163, 2127\u20132137 (2003).","journal-title":"Am. J. Pathol."},{"key":"73406_CR48","doi-asserted-by":"publisher","first-page":"7658","DOI":"10.1128\/JVI.00473-11","volume":"85","author":"B Rockx","year":"2011","unstructured":"Rockx, B. et al. Clinical Outcome of Henipavirus Infection in Hamsters Is Determined by the Route and Dose of Infection. J. Virol. 85, 7658\u20137671 (2011).","journal-title":"J. Virol."},{"key":"73406_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002024","volume":"7","author":"T Geisbert","year":"2013","unstructured":"Geisbert, T. et al. Comparison of the Pathogenicity of Nipah Virus Isolates from Bangladesh and Malaysia in the Syrian Hamster. PLoS Negl. Trop. Dis. 7, e2024 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"73406_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00764-4","volume":"13","author":"V Dewaker","year":"2025","unstructured":"Dewaker, V. et al. Revolutionizing oncology: the role of artificial intelligence (AI) as an antibody design, and optimization tools. Biomark. Res. 13, 52 (2025).","journal-title":"Biomark. Res."},{"key":"73406_CR51","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41401-024-01380-y","volume":"46","author":"XH He","year":"2025","unstructured":"He, X. H. et al. AI-driven antibody design with generative diffusion models: current insights and future directions. Acta Pharmacol. Sin. 46, 565\u2013574 (2025).","journal-title":"Acta Pharmacol. Sin."},{"key":"73406_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50903-y","volume":"15","author":"H He","year":"2024","unstructured":"He, H. et al. De novo generation of SARS-CoV-2 antibody CDRH3 with a pre-trained generative large language model. Nat. Commun. 15, 6867 (2024).","journal-title":"Nat. Commun."},{"key":"73406_CR53","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1073\/pnas.1523303113","volume":"113","author":"JJ Wong","year":"2016","unstructured":"Wong, J. J., Paterson, R. G., Lamb, R. A. & Jardetzky, T. S. Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form. Proc. Natl. Acad. Sci. USA 113, 1056\u20131061 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73406_CR54","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01372-23","volume":"98","author":"PO Byrne","year":"2024","unstructured":"Byrne, P. O. et al. Prefusion stabilization of the Hendra and Langya virus F proteins. J. Virol. 98, e0137223 (2024).","journal-title":"J. Virol."},{"key":"73406_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47213-8","volume":"15","author":"L Chen","year":"2024","unstructured":"Chen, L. et al. Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains. Nat. Commun. 15, 2987 (2024).","journal-title":"Nat. Commun."},{"key":"73406_CR56","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/1743-422X-7-312","volume":"7","author":"D Khetawat","year":"2010","unstructured":"Khetawat, D. & Broder, C. C. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system. Virol. J. 7, 312 (2010).","journal-title":"Virol. J."},{"key":"73406_CR57","doi-asserted-by":"publisher","first-page":"21319","DOI":"10.1021\/acsnano.4c17906","volume":"19","author":"S Chen","year":"2025","unstructured":"Chen, S. et al. An intein-spliced Nipah G protein ferritin nanoparticle vaccine provides complete protection against lethal Nipah virus challenge. ACS Nano 19, 21319\u201321332 (2025).","journal-title":"ACS Nano"},{"key":"73406_CR58","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"73406_CR59","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"73406_CR60","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"73406_CR61","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymeth.2011.07.005","volume":"55","author":"PD Adams","year":"2011","unstructured":"Adams, P. D. et al. The Phenix software for automated determination of macromolecular structures. Methods 55, 94\u2013106 (2011).","journal-title":"Methods"},{"key":"73406_CR62","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/protein\/gzs051","volume":"25","author":"H Ishikawa","year":"2012","unstructured":"Ishikawa, H., Meng, F., Kondo, N., Iwamoto, A. & Matsuda, Z. Generation of a dual-functional split-reporter protein for monitoring membrane fusion using self-associating split GFP. Protein Eng. Des. Sel. 25, 813\u2013820 (2012).","journal-title":"Protein Eng. Des. Sel."},{"key":"73406_CR63","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"73406_CR64","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","volume":"47","author":"G Weng","year":"2019","unstructured":"Weng, G. et al. HawkDock: a web server to predict and analyze the protein-protein complex based on computational docking and MM\/GBSA. Nucleic Acids Res. 47, W322\u2013w330 (2019).","journal-title":"Nucleic Acids Res."},{"key":"73406_CR65","doi-asserted-by":"publisher","first-page":"14203","DOI":"10.1074\/jbc.M900769200","volume":"284","author":"R Gong","year":"2009","unstructured":"Gong, R. et al. Engineered human antibody constant domains with increased stability. J. Biol. Chem. 284, 14203\u201314210 (2009).","journal-title":"J. Biol. Chem."},{"key":"73406_CR66","doi-asserted-by":"publisher","first-page":"D411","DOI":"10.1093\/nar\/gkq1105","volume":"39","author":"RP Joosten","year":"2011","unstructured":"Joosten, R. P. et al. A series of PDB related databases for everyday needs. Nucleic Acids Res. 39, D411\u2013D419 (2011).","journal-title":"Nucleic Acids Res."},{"key":"73406_CR67","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/pro.565","volume":"20","author":"AD Scouras","year":"2011","unstructured":"Scouras, A. D. & Daggett, V. The Dynameomics rotamer library: amino acid side chain conformations and dynamics from comprehensive molecular dynamics simulations in water. Protein Sci. 20, 341\u2013352 (2011).","journal-title":"Protein Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73406-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73406-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73406-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:02:16Z","timestamp":1784764936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73406-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73406"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73406-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Wuhan Institute of Virology has filed a provisional patent related to neutralizing C-Nabs, 1A1-3-22, 2A1-3-8, and the cavity-filling mutants of 2A1-3-8 reported in this paper (Patent No. CN202510271238.6). The inventors are R.G., S.W., S. Chiu, and H.Z. The other authors declare that they have no competing interests in relation to the work described in this manuscript.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6978"}}